TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24846910

Group type: EXPERIMENTAL
Intervention: High-viscosity glass ionomer cement (GIC group)
Number of subjects: 2776

Group type: EXPERIMENTAL
Intervention: Resin-based sealant with fluoride (fluoride-RB group)
Number of subjects: 2776

Group type: COMPARATOR
Intervention: Resin-based sealant without fluoride (RB group)
Number of subjects: 2776
Study: 23855708

Group type: EXPERIMENTAL
Intervention: Complex intervention to reduce dietary glycaemic load and saturated fat intake, and increase physical activity
Number of subjects: 183

Group type: COMPARATOR
Intervention: Routine antenatal care (Control)
Number of subjects: 183
Study: 21729315

Group type: EXPERIMENTAL
Intervention: Patient decision aid
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study: 19248045

Group type: COMPARATOR
Intervention: VBMCP
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: VBMCP + HiCy + IFN
Number of subjects: 268
Study: 16978071

Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both carbohydrate and placebo ingestion
Number of subjects: 12
Study: 15330879

Group type: EXPERIMENTAL
Intervention: Practical Skills intervention (1.5-hour class on practical aspects of breastfeeding)
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Attitudes intervention (two 1-hour classes exploring family and community attitudes toward breastfeeding)
Number of subjects: 981

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 981
Study: 11553140

Group type: EXPERIMENTAL
Intervention: Cool water compresses
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Physiologic saline compresses
Number of subjects: 9
Study: 9480458

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms 3 times a day for 1 month
Number of subjects: 20
Study: 8298198

Group type: EXPERIMENTAL
Intervention: 5 mg alendronate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 20 mg alendronate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 40 mg alendronate
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 6232583

Group type: EXPERIMENTAL
Intervention: Water diuresis alone (group I, n = 19)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day (group II, n = 19)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Neutral phosphate preparation 1500 mg/day (group III, n = 13)
Number of subjects: 51
Study: 31083841

Group type: EXPERIMENTAL
Intervention: Caring for Caregivers program (educational intervention)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 34
Study: 28589504

Group type: EXPERIMENTAL
Intervention: Community mobilization and mobile HTC intervention
Number of subjects: 13755
Study: 27106833

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual exercise
Number of subjects: 110
Study: 25215557

Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg/d)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Vitamin D (50000 IU/wk)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Joint calcium (1000 mg/d) and vitamin D (50000 IU/wk)
Number of subjects: 118
Study: 22179810

Group type: EXPERIMENTAL
Intervention: Glucose-dependent insulinotropic polypeptide (GIP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 0
Study: 20974601

Group type: EXPERIMENTAL
Intervention: telcagepant 140 mg
Number of subjects: 1677

Group type: EXPERIMENTAL
Intervention: telcagepant 280 mg
Number of subjects: 1677

Group type: EXPERIMENTAL
Intervention: telcagepant 140 mg and 280 mg
Number of subjects: 1677

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1677
Study: 18043101

Group type: EXPERIMENTAL
Intervention: Extended transthoracic esophagectomy with en bloc lymphadenectomy
Number of subjects: 220

Group type: COMPARATOR
Intervention: Limited transhiatal esophagectomy
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Extended transthoracic esophagectomy
Number of subjects: 220
Study: 18022088

Group type: EXPERIMENTAL
Intervention: 20-ppm inhaled NO
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard anesthetic gas mixture (control group)
Number of subjects: 20
Study: 15447816

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition with synbiotics (including four kinds of lactic acid bacteria and four kinds of fibers)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Early enteral nutrition with synbiotics (only four kinds of fibers)
Number of subjects: 40
Study: 10910854

Group type: COMPARATOR
Intervention: 0.75% ropivacaine alone (group Ropivacaine, n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine plus 1 microg/kg clonidine (group Ropivacaine‐Clonidine, n = 15)
Number of subjects: 30
Study: 8764789

Group type: EXPERIMENTAL
Intervention: Excimer laser phototherapeutic keratectomy (PTK)
Number of subjects: 26
Study: 1461853

Group type: EXPERIMENTAL
Intervention: One dose of intravenous Augmentin (amoxycillin 250 mg and clavulanic acid 125 mg)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Three doses of intravenous Augmentin (amoxycillin 250 mg and clavulanic acid 125 mg) every 8 hours
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: One dose of intravenous Augmentin
Number of subjects: 900

Group type: COMPARATOR
Intervention: Three doses of intravenous Augmentin
Number of subjects: 900
Study: 6364370

Group type: EXPERIMENTAL
Intervention: Isomil, a soy isolate formula
Number of subjects: 46

Group type: COMPARATOR
Intervention: Similac with Iron, a common milk-based formula
Number of subjects: 46

Group type: COMPARATOR
Intervention: Similac 24 LBW, a hypercaloric milk-based formula
Number of subjects: 46
Study: 30057015

Group type: EXPERIMENTAL
Intervention: Probiotic and selenium co-supplementation (200 μg/day selenium plus 8 × 10^9 CFU/day probiotic)
Number of subjects: 54
Study: 27974102

Group type: EXPERIMENTAL
Intervention: CoQ10 (DDM Chinone®) at a dose of 200 mg×2/day
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 24671488

Group type: EXPERIMENTAL
Intervention: Functional treatment (Tubigrip)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Plaster of Paris (POP)
Number of subjects: 126
Study: 23997992

Group type: EXPERIMENTAL
Intervention: SipSmartER
Number of subjects: 25

Group type: COMPARATOR
Intervention: MoveMore
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study: 21593674

Group type: EXPERIMENTAL
Intervention: Variable stiffness colonoscope
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 110
Study: 19404632

Group type: EXPERIMENTAL
Intervention: Fixed combination (200 mg artesunate + 540 mg amodiaquine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Loose combination (200 mg artesunate + 612 mg amodiaquine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both combinations
Number of subjects: 24
Study: 16188428

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg (group A)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg (group B)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg as sub‐mucosal injection (group C)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (no steroid administration)
Number of subjects: 43
Study: 14514570

Group type: EXPERIMENTAL
Intervention: Annual Diabetes Assessment Program (ADAP) assessments at intervention sites (HbA(1c), blood pressure, lipids, smoking, retinal photos, urine microalbumin, and foot examination)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Annual Diabetes Assessment Program (ADAP) assessments at intervention sites
Number of subjects: 284

Group type: COMPARATOR
Intervention: Comparison sites with ADAP assessments at year 2
Number of subjects: 284
Study: 10937514

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8874840

Group type: EXPERIMENTAL
Intervention: Low birth weight (LBW) children (n = 473)
Number of subjects: 823

Group type: COMPARATOR
Intervention: Normal birth weight (NBW) children (n = 350)
Number of subjects: 823
Study: 1394057

Group type: COMPARATOR
Intervention: Mitomycin C alone
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: MVP (mitomycin C, vinblastine, and cisplatin)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: MVP
Number of subjects: 133
Study: 3838425

Group type: EXPERIMENTAL
Intervention: Orange juice (13 g of carbohydrate)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Whole milk (13 g of carbohydrate)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Skim milk (13 g of carbohydrate)
Number of subjects: 5
Study: 28905341

Group type: EXPERIMENTAL
Intervention: iDrive powered stapling system
Number of subjects: 40

Group type: COMPARATOR
Intervention: EndoGIA conventional stapler
Number of subjects: 40
Study: 30001930

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) plus treatment as usual
Number of subjects: 487

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 487
Study: 26491889

Group type: EXPERIMENTAL
Intervention: Ialuril Soft Gels in hypo-moderate group
Number of subjects: 40

Group type: COMPARATOR
Intervention: RT alone in hypo-moderate group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ialuril Soft Gels in hypo-extreme group
Number of subjects: 40

Group type: COMPARATOR
Intervention: RT alone in hypo-extreme group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ialuril Soft Gels
Number of subjects: 40

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 40
Study: 24946633

Group type: EXPERIMENTAL
Intervention: Two-way quintuple puncture group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Common quintuple puncture group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fire needling group
Number of subjects: 90
Study: 22752862

Group type: EXPERIMENTAL
Intervention: Fidaxomicin 200 mg twice per day for 10 days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Vancomycin 125 mg 4 times per day for 10 days
Number of subjects: 89
Study: 20099952

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Wait-list condition (Control)
Number of subjects: 115
Study: 18058349

Group type: EXPERIMENTAL
Intervention: Exalt
Number of subjects: 0

Group type: COMPARATOR
Intervention: MNL (Commit)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ariva
Number of subjects: 0
Study: 15680854

Group type: EXPERIMENTAL
Intervention: SMA‐CPB (surface modifying active copolymer)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: SMA‐CPB
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: SMA‐CPB and MPSS (methylprednisolone, 1 g intravenous)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: MPSS
Number of subjects: 68
Study: 11487766

Group type: EXPERIMENTAL
Intervention: Juice with high fructose/glucose ratios and sorbitol
Number of subjects: 60
Study: 9580856

Group type: EXPERIMENTAL
Intervention: 185 MBq iodine-131 diagnostic imaging (G1)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Iodine-123 administration only (G0)
Number of subjects: 51
Study: 8282352

Group type: EXPERIMENTAL
Intervention: Intra‐arterial blood pressure after 30 minutes of supine rest
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Arterial plasma epinephrine after 30 minutes of supine rest
Number of subjects: 69

Group type: COMPARATOR
Intervention: Blood pressure at screening and during mental stress and cold pressor tests
Number of subjects: 69
Study: 3177083

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30682632

Group type: EXPERIMENTAL
Intervention: Open Dialogue intervention
Number of subjects: 503

Group type: COMPARATOR
Intervention: Usual psychiatric treatment (control group)
Number of subjects: 503
Study: 28670847

Group type: EXPERIMENTAL
Intervention: GRS based on 17 SNPs
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: GRS based on 34 SNPs
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: GRS based on 51 SNPs
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: GRS based on 68 SNPs
Number of subjects: 3239

Group type: COMPARATOR
Intervention: Negative family history
Number of subjects: 3239

Group type: COMPARATOR
Intervention: Positive family history
Number of subjects: 3239
Study: 25960375

Group type: EXPERIMENTAL
Intervention: PCI + Optimal Medical Therapy (OMT)
Number of subjects: 2287

Group type: EXPERIMENTAL
Intervention: PCI + OMT
Number of subjects: 2287

Group type: COMPARATOR
Intervention: OMT alone
Number of subjects: 2287
Study: 24094693

Group type: EXPERIMENTAL
Intervention: Fast-titration group (150mg/day every 2 days)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Medium-titration group (150mg/day every 4 days)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Slow-titration group (150mg/day every 7 days)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Fast-titration group vs Slow-titration group
Number of subjects: 73

Group type: COMPARATOR
Intervention: Fast-titration group vs Slow-titration group (stratified analysis)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Medium-titration group vs Slow-titration group (stratified analysis)
Number of subjects: 73
Study: 21466609

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (960 mg)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 19001472

Group type: EXPERIMENTAL
Intervention: Culotte stenting with drug-eluting stents (Cypher, Endeavor, polymer-free rapamycin-eluting, Taxus)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Culotte stenting with drug-eluting stents
Number of subjects: 132
Study: 16404596

Group type: EXPERIMENTAL
Intervention: 1‐(11)C‐acetate (ACE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2‐(18)F‐fluoro‐2‐deoxy‐D‐glucose (FDG)
Number of subjects: 26

Group type: COMPARATOR
Intervention: FDG T/C ratio
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: ACE T/C ratio
Number of subjects: 26

Group type: COMPARATOR
Intervention: FDG
Number of subjects: 26

Group type: COMPARATOR
Intervention: T/C ratios and SUVs of FDG uptake
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: T/C ratios and SUVs of ACE uptake
Number of subjects: 26
Study: 12622302

Group type: EXPERIMENTAL
Intervention: Short-term counselling in general practice
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Routine GP treatment + Short-term counselling
Number of subjects: 145

Group type: COMPARATOR
Intervention: Routine GP treatment
Number of subjects: 145
Study: 10861652

Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg once daily for 12 weeks
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Lamivudine treatment continued for 2 years
Number of subjects: 429
Study: 9144683

Group type: COMPARATOR
Intervention: cisplatin/etoposide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: paclitaxel/cisplatin/G-CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: paclitaxel/cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: paclitaxel regimens
Number of subjects: 0
Study: 7525394

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 69
Study: 3131406

Group type: EXPERIMENTAL
Intervention: cromolyn sodium
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: flunisolide
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: beclomethasone
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: glucocorticoids (flunisolide and beclomethasone)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: topical nasal treatment
Number of subjects: 120
Study: 31309730

Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angioplasty
Number of subjects: 0
Study: 27140841

Group type: EXPERIMENTAL
Intervention: Cold-fluid (CF) ingestion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Ice-slurry (IS) ingestion
Number of subjects: 7
Study: 27802427

Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg of transdermal nicotine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24949547

Group type: EXPERIMENTAL
Intervention: Pork group (PG)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Iron supplement group (SG)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 58
Study: 22610268

Group type: EXPERIMENTAL
Intervention: Midodrine 10-30 mg/day
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 19288569

Group type: EXPERIMENTAL
Intervention: Anthracycline plus taxane chemotherapy
Number of subjects: 5486

Group type: COMPARATOR
Intervention: Anthracyclines without taxanes
Number of subjects: 5486

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 5486

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors
Number of subjects: 5486

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Number of subjects: 5486
Study: 17308851

Group type: EXPERIMENTAL
Intervention: Pneumatic dilatation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Laparoscopic cardiomyotomy
Number of subjects: 51
Study: 15362959

Group type: EXPERIMENTAL
Intervention: Octreotide acetate (Sandostatin LAR 10‐30 mg every 4 weeks i.m.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 14
Study: 12077205

Group type: EXPERIMENTAL
Intervention: mu-opioid system activation in response to sustained pain
Number of subjects: 28
Study: 9799818

Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 0
Study: 7621370

Group type: EXPERIMENTAL
Intervention: Loaded trials with linear position feedback to a torque motor
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonloaded trials
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Loaded movements in the deafferented subject
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Movements with load in the absence of vision
Number of subjects: 10
Study: 2495053

Group type: EXPERIMENTAL
Intervention: Health promotion nurse and general practitioner
Number of subjects: 3206

Group type: COMPARATOR
Intervention: General practitioner alone
Number of subjects: 3206
Study: 327987

Group type: EXPERIMENTAL
Intervention: Baclofen (70 to 80 mg daily maximum, titrated)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 106
Study: 6158436

Group type: EXPERIMENTAL
Intervention: 12-15 c/sec EEG feedback training (subgroup I)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 18-23 c/sec EEG feedback training (subgroup II)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 6-9 c/sec EEG feedback training (control period B)
Number of subjects: 8
Study: 31793473

Group type: COMPARATOR
Intervention: Universal adhesive application with no treatment (control)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Universal adhesive application with acid etching (37% phosphoric acid)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Universal adhesive application with Al2O3 sandblasting
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Universal adhesive application with CoJet sandblasting
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: No universal adhesive application with acid etching
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: No universal adhesive application with Al2O3 sandblasting
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: No universal adhesive application with CoJet sandblasting
Number of subjects: 4
Study: 28653433

Group type: EXPERIMENTAL
Intervention: Immediate loading of four interforaminal implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional loading of four interforaminal implants
Number of subjects: 20
Study: 26487284

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Psychoeducational program
Number of subjects: 70
Study: 23395559

Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14
Number of subjects: 544

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Probiotic capsules
Number of subjects: 544
Study: 21162644

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 0
Study: 19453031

Group type: EXPERIMENTAL
Intervention: On-demand therapy with omeprazole 20 mg (Group A1)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Continuous therapy with omeprazole 10 mg daily (Group A2)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily (Group B)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Health-related quality of life evaluation
Number of subjects: 216
Study: 18067032

Group type: EXPERIMENTAL
Intervention: Fagerström Test for Nicotine Dependence (FTND)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time to first cigarette in the morning
Number of subjects: 0
Study: 15060418

Group type: COMPARATOR
Intervention: Saline (placebo) infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 microg/min t‐PA infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 40 microg/min t‐PA infusion
Number of subjects: 6
Study: 12461199

Group type: EXPERIMENTAL
Intervention: Various psychosocial interventions
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Psychosocial treatments
Number of subjects: 34
Study: 10443520

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 62

Group type: COMPARATOR
Intervention: CyA
Number of subjects: 62
Study: 8778009

Group type: COMPARATOR
Intervention: Progesterone concentration in peritoneal fluid
Number of subjects: 100
Study: 2194715

Group type: EXPERIMENTAL
Intervention: terbinafine (125 mg b.i.d.)
Number of subjects: 92

Group type: COMPARATOR
Intervention: griseofulvin (500 mg b.i.d.)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: terbinafine
Number of subjects: 92

Group type: COMPARATOR
Intervention: griseofulvin
Number of subjects: 92